Amgen cholesterol drug reduces artery-clogging plaque in study

Amgen cholesterol drug reduces artery-clogging plaque in study


Amgen Inc's potent new drug Repatha, when added to statin therapy, not only took "bad" LDL cholesterol down to extremely low levels but caused declines in artery-clogging plaque in a majority of high-risk heart patients after 18 months of treatment, according to data from a clinical trial. Amgen had previously announced the study was a success.



from Biotech News